Tiny U.K. Pfizer spinouts start to pop up

A small group of ex-Pfizer ($PFE) employees are launching their own little spinout from the giant R&D complex in Sandwich, which they call a kind of "dating service" for scientists. And they say they are the first of many tiny startups that will launch in the wake of Pfizer's decision to evacuate the drug development hub. "We've certainly learned a lot over the last 5 or 6 months," says Andrew McElroy, the CEO of The Research Network, which will match scientists with biopharma companies. "We've had a lot of help and support as well from government agencies and Pfizer in terms of learning how to set up a new company." Report

Suggested Articles

No biohazardous substances were in the room where the explosion happened, according to the Russian virology center.

Merck has a shot at becoming the first company to receive clearance to sell a vaccine against the virus in the U.S.

Acceleron has chalked up another phase 2 flop as its pipeline thins a little more.